Rolls-Royce share price targets 1,500p ahead of earnings and buyback
Rolls-Royce share price continued soaring last week and reached a record high as market participants waited for its financial results. It jumped to 1,353p, up by 120% in the last…
Novo stock drops 15% as obesity drug falls short in key trial
Shares of Novo Nordisk fell sharply after the company said its next-generation obesity drug CagriSema delivered weaker weight-loss results than a rival treatment from Eli Lilly and Company.Novo said on…
S&P and Dow Jones futures fall as Trump tariffs revive uncertainty
US stock index futures declined on Monday as investors reacted to renewed tariff uncertainty after US President Donald Trump announced a new 15% global duty, even after a Supreme Court…
Domino’s tops Q4 US sales estimates on value push, shares rise 5%
Domino’s Pizza reported stronger-than-expected fourth-quarter US same-store sales on Monday, as aggressive promotions and new menu launches helped draw budget-conscious diners, sending shares up about 5% in premarket trading.The pizza…
Citrini research: S&P 500 to drop 38% from 2026 highs by June 2028
In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial future where the very success of Artificial Intelligence…
Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a $7.8 billion all-cash deal.The stock’s move wasn’t…
Finland’s IQM leads Europe’s quantum push with US listing plan
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.According to a CNBC report, the company said…
We predicted the Blue Owl stock price crash to $10
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel. It dropped to a low of $10.50…
Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its portfolio and ensure smoother launches of new…
Royal Bank of Canada stock double-tops ahead of Q1 earnings
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its all-time high. It has soared by 160%…